Trial Profile
A Bioequivalent Study to Compare Galantamine Oral Solution With Marketed Galantamine Capsule After Single Oral Administration of 10 mg.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2010
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Xian-Janssen
- 29 Jun 2009 New trial record